BioSpace News Archive

Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for Alzheimer’s disease (AD) and related neurodegenerative disorders, today announced that Robert Foerster has been appointed Chief Financial Officer. Mr. Foerster joins Oligomerix with significant financial, strategic and operational experience in the life science industry. “We are very pleased to have Robert j

Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced the company has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Sherlock™ CRISPR SARS-CoV-2 kit for the detection of the virus that causes COVID-19, providing

Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2020 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast on Thursday, May 21, 2020 at 9:00 AM EDT. The Company, which disclosed the move to virtual-only format in all proxy materials related to the 2020 Annual Meeting of Stockholders, has taken this step to support the health and well-being of meeting participants in light of the COVID-19 p

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announced the launch of its new website providing fresh information about Intabio’s Blaze™ iCIEF-MS system. The new website features updated product information and a detail

Preventice Solutions announced the publication of real-world data further validating BeatLogic® deep learning models designed to detect and classify multiple levels of data on heart rhythms gathered using BodyGuardian® remote cardiac monitoring technology.

50 hospitals to date add tele-ICU clinical and operational capacity to address patient surge [07-May-2020] ST. LOUIS , May 7, 2020 /PRNewswire/ -- In response to the urgent need for the treatment of COVID-19 patients amid the current pandemic, Advanced ICU Care , the nation’s leading provider of high-acuity telemedicine, announced accelerated tele-ICU care launches a

Los Angeles-area biomedical research institute participates in 2000-person trial for potential coronavirus treatment

IMV Inc. (“IMV” or the “Company”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines to fight against infectious diseases including COVID-19, today announced that it has completed its previously announced non-brokered private placement (the “Private Placement”) of 8,770,005 units of the Company (each, a “Unit”) at Cdn$2.86 per Unit for

KCR’s Chief Commercial Officer was recognized as a top strategist by the magazine’s editorial staff

Latest Premier survey indicates that shortages of reagents and testing swabs are the main barriers to more widespread testing.